Routine use of corticosteroids to prevent inflammation response in cardiac surgery

Recent Patents on Cardiovascular Drug Discovery

Volumn 7, Issue 3, 2012, Pages 170-174

  Nebelsiek, Tim ^a   Beiras Fernandez, Andres ^b   Kilger, Erich ^a   Möhnle, Patrick ^a   Weis, Florian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Cardiopulmonary bypass; Corticoids; Diabetes; Infections; Inflammation; Postoperative morbidity

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

CARDIOPULMONARY BYPASS; CONTINUOUS INFUSION; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG SAFETY; DRUG USE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INFECTION; INFLAMMATION; INSULIN RESISTANCE; LOADING DRUG DOSE; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RECOMMENDED DRUG DOSE; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HUMANS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84870180838     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489012803832829     Document Type: Review

References (70)

1. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999; 353(9147): 89-92.
2. Gibbon JH, Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954; 37(3): 171-185; passim.
3. Boyle EM, Jr., Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 1997; 63(1): 277-84.
4. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmon-ary bypass. Ann Thorac Surg 1999; 68(3): 1107-1115.
5. Talmor M, Hydo L, Barie PS. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: Effect of intensive care unit resuscitation. Arch Surg 1999; 134(1): 81-7.
6. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215(4): 356-2.
7. Weis F, Kilger E, Beiras-Fernandez A, Nassau K, Reuter D, Goetz A, et al. Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 2006; 61(10): 938-942.
8. Asimakopoulos G. The inflammatory response to CPB: the role of leukocyte filtration. Perfusion 2002; 17 (Suppl): 7-10.
9. Edmunds LH, Jr. Advances in the heart-lung machine after John and Mary Gibbon. Ann Thorac Surg 2003; 76(6): S2220-3.
10. Rubens FD, Mesana T. The inflammatory response to cardiopul-monary bypass: A therapeutic overview. Perfusion 2004; 19 (Suppl 1): S5-12.
11. Moses ML, Camishion RC, Tokunaga K, Pierucci L, Jr., Davies AL, Nealon TF, Jr. Effect of corticosteroid on the acidosis of pro longed cardiopulmonary bypass. J Surg Res 1966; 6(8): 354-60.
12. Motsay GJ, Alho A, Jaeger T, Dietzman RH, Lillehei RC. Effects of corticosteroids on the circulation in shock: experimental and clinical results. Fed Proc 1970; 29(6): 1861-73.
13. Sambhi MP, Weil MH, Udhoji VN. Acute Pharmacodynamic effects of glucocorticoids; cardiac output and related hemodynamic changes in normal subjects and patients in shock. Circulation 1965; 31: 523-30.
14. Celik JB, Gormus N, Okesli S, Gormus ZI, Solak H. Methylpredni-solone prevents inflammatory reaction occurring during cardiopul-monary bypass: effects on TNF-alpha, IL-6, IL-8, IL-10. Perfusion 2004; 19(3): 185-191.
15. Tabardel Y, Duchateau J, Schmartz D, Marecaux G, Shahla M, Barvais L, et al. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996; 119(1): 76-80.
16. Beck IM, Vanden BW, Vermeulen L, Yamamoto KR, Haegeman G, De Bosscher K. Crosstalk in inflammation: The interplay of glu-cocorticoid receptor-based mechanisms and kinases and phospha-tases. Endocr Rev 2009; 30(7): 830-82.
17. Chaney MA. Corticosteroids and cardiopulmonary bypass: A review of clinical investigations. Chest 2002; 121(3): 921-931.
18. Mayumi H, Zhang QW, Nakashima A, Masuda M, Kohno H, Ka-wachi Y, et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg 1997; 63(1): 129-37.
19. Tassani P, Richter JA, Barankay A, Braun SL, Haehnel C, Spaeth P, et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth 1999; 13(2): 165-72.
20. Liakopoulos OJ, Schmitto JD, Kazmaier S, Brauer A, Quintel M, Schoendube FA, et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg 2007; 84(1): 110-8; discussion 118-119.
21. Andersen LW, Baek L, Thomsen BS, Rasmussen JP. Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Anesth 1989; 3(5): 544-549.
22. Anic D, Gasparovic H, Ivancan V, Batinic D. Effects of corticos-teroids on inflammatory response following cardiopulmonary bypass. Croat Med J 2004; 45(2): 158-161.
23. Boldt J, von Bormann B, Kling D, Jooss D, Moosdorf R, Hempel-mann G. [Effect of glucocorticoids on extravascular lung water following extra-corporeal circulation]. Anaesthesist 1986; 35(4): 238-244.
24. Boscoe MJ, Yewdall VM, Thompson MA, Cameron JS. Complement activation during cardiopulmonary bypass: Quantitative study of effects of methylprednisolone and pulsatile flow. Br Med J (Clin Res Ed) 1983; 287(6407): 1747-50.
25. Engelman RM, Rousou JA, Flack JE, 3rd, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 1995; 60(3): 801-4.
26. Fosse E, Mollnes TE, Osterud A, Aasen AO. Effects of methyl-prednisolone on complement activation and leukocyte counts during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 1987; 21(3): 255-61.
27. Harig F, Cesnjevar R, Mahmoud FO, von der Emde J. Periopera-tive factors influencing interleukin-10 release under cardiopulmon-ary bypass. Thorac Cardiovasc Surg 1999; 47(6): 361-8.
28. Hill GE, Alonso A, Thiele GM, Robbins RA. Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardio-pulmonary bypass in humans. Anesth Analg 1994; 79(1): 23-7.
29. Jansen NJ, van Oeveren W, van Vliet M, Stoutenbeek CP, Eysman L, Wildevuur CR. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Car-diothorac Surg 1991; 5(4): 211-7.
30. Jorens PG, De Jongh R, De Backer W, Van Damme J, Van Overveld F, Bossaert L, et al. Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am Rev Respir Dis 1993; 148(4 Pt 1): 890-5.
31. Karlstad MD, Patteson SK, Guszcza JA, Langdon R, Chesney JT. Methylprednisolone does not influence endotoxin translocation during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993; 7(1): 23-7.
32. Kawamura T, Inada K, Nara N, Wakusawa R, Endo S. Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med 1999; 27(3): 545-548.
33. Kawamura T, Inada K, Okada H, Okada K, Wakusawa R. Methyl-prednisolone inhibits increase of interleukin 8 and 6 during open heart surgery. Can J Anaesth 1995; 42(5 Pt 1): 399-403.
34. Loubser PG. Effect of methylprednisolone on complement activation during heparin neutralization. J Cardiovasc Pharmacol 1997; 29(1): 23-27.
35. Tassani P, Richter JA, Eising GP, Barankay A, Braun SL, Haehnel CH, Spaeth P, Schad H, Meisner H. Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting. J Cardiothorac Vasc Anesth 1999; 13(3): 285-91.
36. Tennenberg SD, Bailey WW, Cotta LA, Brodt JK, Solomkin JS. The effects of methylprednisolone on complement-mediated neu-trophil activation during cardiopulmonary bypass. Surgery 1986; 100(2): 134-42.
37. Toft P, Christiansen K, Tonnesen E, Nielsen CH, Lillevang S. Effect of methylprednisolone on the oxidative burst activity, adhesion molecules and clinical outcome following open heart surgery. Scand Cardiovasc J 1997; 31(5): 283-8.
38. Vallejo JL, Gimenez-Fernandez R, Mainer JL, Rivera R. [Clinical analysis of the protective effect of methylprednisolone on the heart in anoxic arrest (random study)]. Rev Esp Cardiol 1977; 30(6 Pt 2): 705-9.
39. Wan S, LeClerc JL, Huynh CH, Schmartz D, DeSmet JM, Yim AP, Vincent JL. Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass? J Thorac Cardiovasc Surg 1999; 117(5): 1004-8.
40. Wan S, LeClerc JL, Schmartz D, Barvais L, Huynh CH, Deviere J, DeSmet JM, Vincent JL. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 1997; 133(3): 335-9.
41. Chaney MA, Durazo-Arvizu RA, Nikolov MP, Blakeman BP, Bakhos M. Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation. J Thorac Cardiovasc Surg 2001; 121(3): 561-9.
42. Chaney MA, Nikolov MP, Blakeman B, Bakhos M, Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 1998; 87(1): 27-33.
43. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M, Slogoff S. Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation. Ann Thorac Surg 1999; 67(4): 1006-1011.
44. Coffin LH, Shinozaki T, DeMeules JE, Browdie DA, Deane RS, Morgan JG. Ineffectiveness of methylprednisolone in the treatment of pulmonary dysfunction after cardiopulmonary bypass. Am J Surg 1975; 130(5): 555-9.
45. Fecht DC, Magovern GJ, Park SB, Merkow LP, Dixon CM, Dosios T, et al. Beneficial effects of methylprednisolone in patients on cardiopulmonary bypass. Circ Shock 1978; 5(4): 415-422.
46. Fillinger MP, Rassias AJ, Guyre PM, Sanders JH, Beach M, Pahl J, et al. Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery. J Cardiothorac Vasc Anesth 2002; 16(2): 163-9.
47. Heikkinen L, Harjula A, Merikallio E. Acute renal failure related to open-heart surgery. Ann Chir Gynaecol 1985; 74(5): 203-9.
48. Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31(4): 1068-74.
49. Loef BG, Henning RH, Epema AH, Rietman GW, van Oeveren W, Navis GJ, et al. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2004; 93(6): 793-8.
50. Mangos GJ, Brown MA, Chan WY, Horton D, Trew P, Whitworth JA. Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Aust N Z J Med 1995; 25(4): 284-289.
51. Miranda DR, Stoutenbeek C, Karliczek G, Rating W. Effects of dexamethason on the early postoperative course after coronary artery bypass surgery. Thorac Cardiovasc Surg 1982; 30(1): 21-27.
52. Morton JR, Hiebert CA, Lutes CA, White RL. Effect of methyl-prednisolone on myocardial preservation during coronary artery surgery. Am J Surg 1976; 131(4): 419-22.
53. Niazi Z, Flodin P, Joyce L, Smith J, Mauer H, Lillehei RC. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest 1979;76(3): 262-8.
54. Oliver WC, Jr., Nuttall GA, Orszulak TA, Bamlet WR, Abel MD, Ereth MH, et al. Hemofiltration but not steroids results in earlier tracheal extubation following cardiopulmonary bypass: A prospective, randomized double-blind trial. Anesthesiology 2004; 101(2): 327-39.
55. Rao G, King J, Ford W, King G. The effects of methylprednisolone on the complications of coronary artery surgery. Vasc Surg 1977; 11(1): 1-7.
56. Toledo-Pereyra LH, Lin CY, Kundler H, Replogle RL. Steroids in heart surgery: A clinical double-blind and randomized study. Am Surg 1980; 46(3): 155-60.
57. von Spiegel T, Giannaris S, Wrigge H, Schorn B, Hoeft A. [Effects of dexamethasone on extravascular lung water and pulmonary haemodynamics in patients undergoing coronary artery bypass surgery]. Anasthesiol Intensivmed Notfallmed Schmerzther 2001; 36(9): 545-51.
58. Yared JP, Starr NJ, Hoffmann-Hogg L, Bashour CA, Insler SR, O'Connor M 3rd, et al, Dexamethasone decreases the incidence of shivering after cardiac surgery: A randomized, double-blind, placebo-controlled study. Anesth Analg 1998; 87(4): 795-9.
59. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: A dose-response meta-analysis. Circulation 2009; 119(14): 1853-66.
60. Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K, et al. Clinical benefit of steroid use in patients undergoing car-diopulmonary bypass: A meta-analysis of randomized trials. Eur Heart J 2008; 29(21): 2592-600.
61. Dieleman JM, van Paassen J, van Dijk D, Arbous MS, Kalkman CJ, Vandenbroucke JP, et al. Prophylactic corticosteroids for car-diopulmonary bypass in adults. Cochrane Database Syst Rev (5): CD005566.
62. Halonen J, Halonen P, Jarvinen O, Taskinen P, Auvinen T, Tarkka M, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A randomized controlled trial. Jama 2007; 297(14): 1562-7.
63. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345(19): 1359-67.
64. Kilickan L, Yumuk Z, Bayindir O. The effect of combined prein-duction thoracic epidural anaesthesia and glucocorticoid administration on perioperative interleukin-10 levels and hyperglycemia. A randomized controlled trial. J Cardiovasc Surg 2008; 49(1): 87-93.
65. Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 2004(4): CD003611.
66. Weis F, Beiras-Fernandez A, Schelling G, Briegel J, Lang P, Hauer D, et al. Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: Effects on interleukin-6 to interleukin-10 ratio and early outcome. Crit Care Med 2009; 37(5): 1685-90.
67. Spiik, A.K., Löfberg, R., Bandholtz, L., Von Stein, O., Zargari, A. Modulating responsiveness to steroids. EP2179737 (2010).
68. MacNevin, C., Stein, D., Liotta, D., Sayeed, I., Guthrie, D.B., Lockwood, M.A., Natchus, M.G. Steroid analogues for neuropro-tection. WO2009108804 (2009).
69. Whitehead, A.S. Methods for determining steroid responsiveness US6878518 (2005).
70. Clark, A.F. Angiostatic steroids. US6011023 (2000).